• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problems Perforation (2001); Deformity/ Disfigurement (2360)
Event Date 02/04/2021
Event Type  Injury  
Event Description
The patient underwent a surgical procedure to remove and replace this tactra malleable penile prosthesis due to the tips not extending into the glans causing a tilted appearance.A new tactra device was implanted.It was noted that length of the device may have been incorrect in addition to the possibility that a perforation occurred during implant.No additional information was reported.
 
Manufacturer Narrative
This report is being submitted to provide corrected event information as well as additional information received since the previous report.
 
Event Description
The patient underwent a surgical procedure to remove and replace this tactra malleable penile prosthesis due to the tips not extending into the glans causing a tilted appearance.A new tactra device was implanted.It was noted that length of the device may have been incorrect in addition to the possibility that a perforation occurred during implant.No additional information was reported.Additional information was received that during the original procedure, only one cylinder was removed and replaced.Approximately two months later, another procedure was performed wherein the other original cylinder was removed and replaced to further address the continued tilted appearance.
 
Manufacturer Narrative
This report is being submitted to provide additional product information.
 
Event Description
The patient underwent a surgical procedure to remove and replace this tactra malleable penile prosthesis due to the tips not extending into the glans causing a tilted appearance.A new tactra device was implanted.It was noted that length of the device may have been incorrect in addition to the possibility that a perforation occurred during implant.No additional information was reported.Additional information was received that during the original procedure, only one cylinder was removed and replaced.Approximately two months later, another procedure was performed wherein the other original cylinder was removed and replaced to further address the continued tilted appearance.
 
Manufacturer Narrative
Investigation summary: with all the available information, boston scientific concludes as no further information regarding this event is expected, our investigation is complete.This report will be updated should additional information be provided.Device history record review: a review of the device history record (dhr) was performed.The review of the dhr identified that there were no process related non-conformances, scrap, or rework performed during the production that could explain the event.The reviews ensure each device meets specification prior to release for use.There is no indication the device manufacturing process contributed to the reported complaint.Device technical analysis: a single tactra cylinder was returned for analysis.The cylinder was visually and microscopically inspected.The rear tip of the cylinder was identified to be trimmed to approximately 154mm with the use of a sharp instrument.Based on the nature of the observed damage, it was determined that it likely occurred during the implant procedure.Labeling review: perforation is listed as a potential adverse event in the instructions for use (ifu).Review of labeling determined the complaint situation was listed in the manual.There was no indication in the complaint that the product was not used in accordance to the labeling.The manual was unlikely to be the cause of the reported complaint.Investigation conclusion: no further actions are considered necessary and the complaint investigation conclusion code is unintended use error caused or contributed to event.
 
Event Description
The patient underwent a surgical procedure to remove and replace this tactra malleable penile prosthesis due to the tips not extending into the glans causing a tilted appearance.A new tactra device was implanted.It was noted that length of the device may have been incorrect in addition to the possibility that a perforation occurred during implant.No additional information was reported.Additional information was received that during the original procedure, only one cylinder was removed and replaced.Approximately two months later, another procedure was performed wherein the other original cylinder was removed and replaced to further address the continued tilted appearance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key11358518
MDR Text Key232829682
Report Number2183959-2021-00603
Device Sequence Number1
Product Code FAE
Combination Product (y/n)N
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup,Followup
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0024047833
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer05/20/2021
Initial Date Manufacturer Received 02/04/2021
Initial Date FDA Received02/22/2021
Supplement Dates Manufacturer Received04/15/2021
04/16/2021
06/10/2021
Supplement Dates FDA Received04/15/2021
05/04/2021
06/11/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age68 YR
-
-